GC Biopharma Corp
3 clinical trials · 3 recruiting · INDUSTRY
Trials by GC Biopharma Corp
RECRUITINGPhase 1NCT06567769
Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of recombinant human heparan N-sulfatase (rhHNS, GC1130A)...
Sponsor: GC Biopharma CorpEnrolling: 95 locations
Sanfilippo Syndrome Type A
RECRUITINGPhase 3NCT05686759
A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
The purpose of this study is to evaluate the efficacy and safety of undiluted intravenous infusion of I.V.-Hepabig inj. in post-liver transplant patients
Sponsor: GC Biopharma CorpEnrolling: 1058 locations
Hepatitis B
RECRUITINGPhase 1 / Phase 2NCT06858397
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
This Phase 1/2 first-in-human (FIH) study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15421 in patients with FD.
Sponsor: GC Biopharma CorpEnrolling: 1810 locations
Fabry Disesase